Literature DB >> 19670446

Fertility preservation in young women with epithelial ovarian cancer.

Jason D Wright1, Monjri Shah, Leny Mathew, William M Burke, Jennifer Culhane, Noah Goldman, Peter B Schiff, Thomas J Herzog.   

Abstract

BACKGROUND: Surgical management of ovarian cancer consists of hysterectomy with bilateral oophorectomy. In young women, this results in the loss of reproductive function and estrogen deprivation. In the current study, the authors examined the safety of fertility-conserving surgery in premenopausal women with epithelial ovarian cancers.
METHODS: Women aged<or=50 years with stage IA or IC epithelial ovarian cancer who were registered in the Surveillance, Epidemiology, and End Results database were examined. Patients who underwent bilateral oophorectomy were compared with those who underwent ovarian conservation. A second analysis examined uterine conservation versus hysterectomy. Multivariate Poisson regression models were developed to describe predictors of fertility preservation. Survival was examined using Cox proportional hazards models and the Kaplan-Meier method.
RESULTS: In total, 1186 women, including 754 women (64%) who underwent bilateral oophorectomy and 432 women (36%) who underwent ovarian preservation, were identified. Younger age, later year of diagnosis, and residence in the eastern or western United States were associated with ovarian preservation (P<.05 for all). Women with endometrioid and clear cell histologies and stage IC disease were less likely to have ovarian conservation (P<.05). In a Cox model, ovarian preservation had no effect on survival (hazard ratio [HR], 0.69; 95% confidence interval [CI], 0.39-1.20). Young age, later year of diagnosis, residence in the eastern or western United States, single women, mucinous tumors, and patients with stage IA disease were more likely to have uterine preservation (P<.05 for all). In a multivariate model, uterine preservation had no effect on survival (HR, 0.87; 95% CI, 0.62-1.22).
CONCLUSIONS: Ovarian and uterine-conserving surgery were safe in young women who had stage IA and IC epithelial ovarian cancer. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19670446     DOI: 10.1002/cncr.24461

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

1.  Clinical outcomes of fertility-sparing treatments in young patients with epithelial ovarian carcinoma.

Authors:  Jun Hu; Li-rong Zhu; Zhi-qing Liang; Yuan-guang Meng; Hong-yan Guo; Peng-peng Qu; Cai-ling Ma; Cong-jian Xu; Bi-bo Yuan
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

2.  Serum microRNA-145 as a novel biomarker in human ovarian cancer.

Authors:  Huichao Liang; Zhipeng Jiang; Guie Xie; Yan Lu
Journal:  Tumour Biol       Date:  2015-02-27

3.  Expression and clinical significance of BIRC6 in human epithelial ovarian cancer.

Authors:  Lin Wang; Yan-Jie Chen; Jun Hou; Ya-Yun Wang; Wen-Qing Tang; Xi-Zhong Shen; Rui-Qin Tu
Journal:  Tumour Biol       Date:  2014-01-23

4.  High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer.

Authors:  Lin Wang; Yan-Jie Chen; Kai Xu; Ya-Yun Wang; Xi-Zhong Shen; Rui-Qin Tu
Journal:  Tumour Biol       Date:  2014-08-15

Review 5.  Mucinous tumors of the ovary: current thoughts on diagnosis and management.

Authors:  Jubilee Brown; Michael Frumovitz
Journal:  Curr Oncol Rep       Date:  2014-06       Impact factor: 5.075

6.  Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.

Authors:  Zhanzhan Xu; Yu Zhou; Yexuan Cao; Thi Lan Anh Dinh; Jing Wan; Min Zhao
Journal:  Med Oncol       Date:  2016-10-18       Impact factor: 3.064

7.  Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis.

Authors:  Ruru Zhu; Jisen Xue; Huijun Chen; Qian Zhang
Journal:  Oncol Lett       Date:  2020-08-21       Impact factor: 2.967

Review 8.  MicroRNAs in ovarian carcinomas.

Authors:  Neetu Dahiya; Patrice J Morin
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

9.  Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age.

Authors:  Maya Hanatani; Nobuhisa Yoshikawa; Kosuke Yoshida; Satoshi Tamauchi; Yoshiki Ikeda; Kimihiro Nishino; Kaoru Niimi; Shiro Suzuki; Michiyasu Kawai; Hiroaki Kajiyama; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2019-09-20       Impact factor: 3.402

10.  Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery.

Authors:  Lorna A Brudie; Giorgia Gaia; Sarfraz Ahmad; Neil J Finkler; Glenn E Bigsby; Giselle B Ghurani; James E Kendrick; Joseph A Rakowski; Jessica H Groton; Robert W Holloway
Journal:  J Robot Surg       Date:  2011-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.